Skip to main content
Watch Insiders
ACRSHealthcare

Aclaris Therapeutics Inc (ACRS) Insider Trading

In the last 90 days, no Aclaris Therapeutics Inc (ACRS) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Apr 23, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Apr 23, 2026Braden Michael Leonard10% OwnerSale300,000$4.53$1,359,000

Common questions

ACRS insider trading FAQ

Are ACRS insiders buying or selling?
No ACRS insiders reported open-market purchases or sales in the last 90 days.
When was the last ACRS insider purchase?
No open-market insider purchase of Aclaris Therapeutics Inc stock was reported in the last 90 days.
Where does ACRS insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Aclaris Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.